3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
Related Content
August 20, 2012 — Abbott today announced that the Xience Xpedition everolimus-eluting coronary stent system received CE ...
August 20, 2012
August 9, 2012 — The Harvard Clinical Research Institute (HCRI) announced today the successful completion of ...
August 09, 2012
Aug. 8, 2012 — The U.S. Food and Drug Administration (FDA) has approved Abbott’s Omnilink Elite Vascular Balloon ...
August 08, 2012
Feature | Kamran Zamanian, Ph.D.
As the average age of the U.S. population and the number of patients at high risk for cardiovascular disease increase ...
July 17, 2012
Feature | Marianne Pop, Pharm.D., BCPS
Anticoagulants, primarily warfarin, are used to prevent thrombosis and thromboembolism in patients with atrial ...
July 12, 2012April 23, 2012 - Abbott and St. Jude Medical announced ChoiceAlliance, a multi-year joint initiative that provides ...
April 23, 2012
April 12, 2012 – Abbott announced approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next ...
April 17, 2012
March 29, 2012 – Two-year follow-up data from the pivotal PLATINUM Workhorse trial comparing the safety and ...
March 29, 2012
Feature | Mark Michael, M.D., and Jeffrey A. Breall, M.D., Ph.D.
Management of coronary chronic total occlusion (CTO) is individualized depending on the severity of symptoms, ischemia ...
March 19, 2012
Feature | Mark Paquin
April 15, 2012, will mark the 10th anniversary of the approval of the first drug-eluting stent (DES). Ten years ago, the ...
March 16, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now